Lifestyle Intervention Benefits Cognition in Older Adults With Low Hippocampal Volume

Precision Prevention in the Era of Multidomain Lifestyle Interventions

The global rise in dementia prevalence has shifted clinical focus toward aggressive risk reduction through multidomain lifestyle interventions targeting diet, exercise, and vascular health [1, 2]. While large-scale trials have demonstrated that these combined strategies can improve global cognition in at-risk older adults, the results across different populations remain heterogeneous [3, 4]. Identifying the specific neurobiological mechanisms that drive these cognitive improvements is essential for refining preventive care [5, 6]. Furthermore, clinicians currently lack validated biomarkers to determine which patients are most likely to benefit from intensive behavioral coaching versus self-guided lifestyle changes [7, 8]. A new study now offers fresh insights into how baseline brain characteristics and longitudinal biomarker changes influence the efficacy of these preventive strategies.

Trial Design and the US POINTER Imaging Cohort

The POINTER Imaging study was designed as an ancillary component of the US POINTER trial, a 2-year, single-blind multicenter randomized clinical trial. The researchers conducted the study from May 2019 to March 2023, with the final follow-up data collection occurring on May 14, 2025. To qualify for enrollment, participants were required to be between 60 and 79 years of age and demonstrate a sedentary lifestyle and a suboptimal diet. Furthermore, eligibility necessitated the presence of at least two additional risk criteria for cognitive decline, such as a family history of dementia or specific vascular risk factors. This targeted recruitment ensured that the study population consisted of older adults at elevated risk for future cognitive impairment. Among the 1,943 participants enrolled in the parent trial, a sub-cohort of 983 individuals underwent at least one magnetic resonance imaging (MRI) or positron emission tomography (PET) scanning session to evaluate brain biomarkers. The mean age of this imaging cohort was 68.4 years (SD 5.2). The group was composed of 605 female participants (61.5%) and 378 male participants (38.5%). These imaging sessions allowed the authors to measure primary outcomes including global beta-amyloid burden, tau burden in the entorhinal cortex (a region of the temporal lobe critical for memory), hippocampal volume, and white matter hyperintensity volume (a marker of small vessel ischemic disease). Participants were randomly assigned to one of two intervention arms: the structured intervention (n = 516) or the self-guided intervention (n = 467). Both protocols emphasized four key domains of lifestyle modification: increased physical and cognitive activity, healthy nutrition, social engagement, and cardiovascular health monitoring. The primary distinction between the groups was the level of support provided; the structured intervention featured higher intensity and greater accountability through frequent coaching and monitored activities, while the self-guided group received similar health education but with less frequent professional oversight. This comparison was designed to determine if the rigor of the intervention influenced cognitive preservation in the context of existing brain pathology.

Stability of Neuroimaging Biomarkers Across Interventions

The researchers evaluated the impact of the lifestyle interventions using four primary imaging outcomes: global beta-amyloid burden, tau burden in the entorhinal cortex (a region of the medial temporal lobe that serves as a primary hub for memory and navigation), hippocampal volume, and white matter hyperintensity volume (a marker of small vessel ischemic disease). To assess the functional impact of these structural and molecular markers, the study utilized a global cognitive composite as the primary cognitive measure. Despite the intensive nature of the structured intervention, the analysis revealed that there were no intervention group differences in longitudinal cognitive or imaging outcomes. This indicates that the high-intensity lifestyle coaching did not significantly alter the trajectory of brain atrophy, the accumulation of proteinopathies, or the progression of white matter disease over the two-year study period. Further investigation into the role of Alzheimer disease pathology showed that intervention group differences were not associated with or moderated by beta-amyloid status or accumulation. This finding suggests that the cognitive benefits observed in certain subgroups were not driven by a reduction in amyloid plaque burden or a slowing of its deposition. For the practicing clinician, these results underscore a critical distinction between symptomatic cognitive preservation and the modification of underlying neuropathological processes. While lifestyle modifications remain a cornerstone of dementia risk reduction, these data suggest that such interventions may function through mechanisms of brain resilience or cognitive reserve rather than by directly reversing or halting the biological markers of neurodegeneration.

Hippocampal Volume as a Predictor of Clinical Response

While the lifestyle interventions did not alter the overall trajectory of brain biomarkers, the researchers identified specific neuroimaging characteristics that predicted which patients would derive the most cognitive benefit from intensive coaching. A primary finding involved the baseline volume of the hippocampus, a brain region critical for memory formation and one of the first areas to show atrophy in Alzheimer disease. The study demonstrated that lower baseline hippocampal volume was associated with greater cognitive benefit for participants in the structured group compared to the self-guided group. Specifically, for participants who entered the trial with lower hippocampal volumes, the structured intervention yielded a cognitive benefit of 0.077 standard deviations (95% CI, 0.022 to 0.132). In contrast, participants with higher baseline hippocampal volumes saw a negligible cognitive benefit of only 0.002 standard deviations (95% CI, -0.037 to 0.041). The interaction p-value for baseline hippocampal volume and cognitive benefit was .03, suggesting that structural imaging may serve as a tool for identifying high-risk patients who require more intensive, supervised support to maintain cognitive function. The study also examined the relationship between cognitive performance and the accumulation of tau protein in the entorhinal cortex, an area of the brain that acts as a gateway between the hippocampus and the neocortex. In the self-guided intervention group, the researchers found a negative association between change in entorhinal cortex tau and change in global cognition, meaning that as tau burden increased, cognitive scores declined. However, this negative association was attenuated in the structured intervention group, where the intensive lifestyle support appeared to decouple tau accumulation from cognitive decline. The difference in association between the two groups was 0.289 (95% CI, 0.029 to 0.550), with an interaction p-value of .03. These findings suggest that while the intervention does not stop the biological progression of tau pathology, a structured multidomain lifestyle program may enhance cognitive resilience, allowing patients to maintain better function despite the presence of underlying neurodegenerative markers.

References

1. Bereczki E, Mangialasche F, Barbera M, et al. Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches.. The journal of prevention of Alzheimer's disease. 2025. doi:10.1016/j.tjpad.2025.100367

2. Castro CB, Costa LM, Dias CB, et al. Multi-Domain Interventions for Dementia Prevention - A Systematic Review.. The journal of nutrition, health & aging. 2023. doi:10.1007/s12603-023-2046-2

3. Coley N, Giulioli C, Aisen P, Vellas B, Andrieu S. Randomised Controlled Trials for the Prevention of Cognitive Decline or Dementia: A Systematic Review.. Ageing Research Reviews. 2022. doi:10.1016/j.arr.2022.101777

4. Baker LD, Espeland M, Whitmer R, et al. Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.. 2025. doi:10.1001/jama.2025.12923

5. Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduction and Targeted Therapy. 2024. doi:10.1038/s41392-024-01911-3

6. Loenen MRV, Remie LB, Trijp MPV, et al. The Effects of a Multidomain Lifestyle Intervention on Brain Function and Its Relation With Immunometabolic Markers and Intestinal Health in Older Adults at Risk of Cognitive Decline: Study Design and Baseline Characteristics of the HELI Randomized Controlled Trial.. JMIR research protocols. 2025. doi:10.2196/69814

7. Mendes AJ, Ribaldi F, Sayin O, et al. Single-domain and multidomain lifestyle interventions for the prevention of cognitive decline in older adults who are cognitively unimpaired: a systematic review and network meta-analysis.. The Lancet Healthy Longevity. 2025. doi:10.1016/j.lanhl.2025.100762

8. Brodaty H, Chau T, Heffernan M, et al. An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial.. Nature medicine. 2025. doi:10.1038/s41591-024-03351-6